(Q63728608)

English

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

scientific article published on 01 February 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit